Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
Clinical trial NCT03587129 · TERMINATED
Trial details
- NCT number
- NCT03587129
- Sponsor
- First Affiliated Hospital of Harbin Medical University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2020-06-14
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.